Chemocentryx (CCXI) Reports Q4 EPS of 61c, Revs Double

Chemocentryx (NASDAQ: CCXI) reported Q4 EPS of $0.61, versus $0.17 reported last year. Revenue for the quarter came in at $26.1 thousand, versus $13.1 million reported last year.

For earnings history and earnings-related data on Chemocentryx (CCXI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Exyn Technologies, Inc. (EXYN) Reports Q2 Loss of $1.55
• Coty (COTY) Misses Q4 EPS by 1c, offers outlook